1-2 of 2
Keywords: IgA nephropathy
Close
Sort by
Articles
Clin Sci (Lond) (2024) 138 (11): 645–662.
Published: 29 May 2024
... that despite this evidence, RASi represented by ACEis or ARBs remains a mainstay of nonimmunosuppressive nephroprotective treatment [ 21 ]. Angiotensin II Endothelin Type A receptor Endothelin-1 FSGS IgA nephropathy Sparsentan Travere Therapeutics, Inc. Evidence collected over...
Articles